Ulysses Neuroscience Limited (UNL) is an Irish SME aimed at advancing knowledge and treatment of brain disorders by providing clinical and preclinical research services to pharmaceutical companies to accelerate their drug discovery programmes in neuropsychiatric, rare neurodevelopmental and neurodegenerative disorders. We are committed to re-incorporating humanity into all aspects of how we do science. The company is based on three core values which directly drive our research and interaction with pharmaceutical companies: patient-centricity, social responsibility and translational research.
BrainXell provides high-purity, iPSC-derived human neurons and glia for research and development with a focus on drug discovery. Utilizing proprietary technology, we generate high-purity, subtype-specific neurons that mature rapidly and are quickly and easily ready for a variety of assays. Multiple neuron subtypes relevant to a range of disorders are available. Additionally, each neuron subtype can be made in custom batches from 50 million to 10 billion neurons from unique iPSC lines. We are dedicated to delivering the highest quality products for off-the-shelf neurons and custom service projects.